Dj Micron Technology Inc. Stock Slides 3.2%, Underperforms Market

Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Industrials, Telecoms and Technology sectors led shares higher while losses in the Consumer Services, Healthcare and Basic Materials sectors led shares lower.

At the close in NYSE, the Dow Jones Industrial Average fell 0.07%, while the S&P 500 index climbed 0.11%, and the NASDAQ Composite index climbed 0.22%.

The best performers of the session on the Dow Jones Industrial Average were Salesforce Inc (NYSE:CRM), which rose 3.66% or 8.74 points to trade at 247.46 at the close. Meanwhile, NVIDIA Corporation (NASDAQ:NVDA) added 2.13% or 3.82 points to end at 183.40 and International Business Machines (NYSE:IBM) was up 1.76% or 5.34 points to 307.96 in late trade.

The worst performers of the session were 3M Company (NYSE:MMM), which fell 2.21% or 3.82 points to trade at 169.27 at the close. Home Depot Inc (NYSE:HD) declined 1.88% or 6.74 points to end at 351.17 and Unitedhealth Group (NYSE:UNH) was down 1.83% or 6.22 points to 333.49.

The top performers on the S&P 500 were Dollar General Corporation (NYSE:DG) which rose 14.01% to 125.29, Enphase Energy Inc (NASDAQ:ENPH) which was up 4.73% to settle at 30.78 and MarketAxess Holdings Inc (NASDAQ:MKTX) which gained 4.72% to close at 167.25.

The worst performers were Intel Corporation (NASDAQ:INTC) which was down 7.43% to 40.51 in late trade, LyondellBasell Industries NV (NYSE:LYB) which lost 6.25% to settle at 43.16 and Albemarle Corp (NYSE:ALB) which was down 5.81% to 119.14 at the close.

The top performers on the NASDAQ Composite were SMX Security Matters Ord Shs Class A (NASDAQ:SMX) which rose 141.07% to 141.00, Polyrizon Ltd (NASDAQ:PLRZ) which was up 104.51% to settle at 14.50 and Synchronoss Technologies Inc (NASDAQ:SNCR) which gained 64.34% to close at 8.71.

The worst performers were Nano Labs Ltd ADR (NASDAQ:NA) which was down 27.18% to 3.00 in late trade, Nauticus Robotics Inc (NASDAQ:KITT) which lost 25.00% to settle at 1.17 and Super X AI Technology Ltd (NASDAQ:SUPX) which was down 20.98% to 18.53 at the close.

Falling stocks outnumbered advancing ones on the New York Stock Exchange by 1378 to 1373 and 85 ended unchanged; on the Nasdaq Stock Exchange, 2012 rose and 1330 declined, while 196 ended unchanged.

Shares in Dollar General Corporation (NYSE:DG) rose to 52-week highs; up 14.01% or 15.40 to 125.29. Shares in Nano Labs Ltd ADR (NASDAQ:NA) fell to 52-week lows; falling 27.18% or 1.12 to 3.00.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 1.87% to 15.78 a new 1-month low.

Gold Futures for February delivery was up 0.16% or 6.70 to $4,239.20 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 1.36% or 0.80 to hit $59.75 a barrel, while the February Brent oil contract rose 1.10% or 0.69 to trade at $63.36 a barrel.

EUR/USD was unchanged 0.22% to 1.16, while USD/JPY fell 0.10% to 155.12.

The US Dollar Index Futures was up 0.25% at 99.04.

Investing.com – Mexico stocks were higher after the close on Thursday, as gains in the Industrials, Consumer Goods & Services and Consumer Staples sectors led shares higher.

At the close in Mexico, the S&P/BMV IPC rose 0.12%.

The best performers of the session on the S&P/BMV IPC were Qualitas Controladora, SAB De CV (BMV:Q), which rose 3.45% or 5.98 points to trade at 179.43 at the close. Meanwhile, Promotora y Operadora de Infraestructura SAB de CV (BMV:PINFRA) added 3.32% or 8.37 points to end at 260.23 and Grupo Carso, S.A.B. De C.V. (BMV:GCARSOA1) was up 2.33% or 2.86 points to 125.64 in late trade.

The worst performers of the session were Becle SA (BMV:CUERVO), which fell 4.06% or 0.88 points to trade at 20.82 at the close. Grupo Aeroportuario del Pacifico SAB De CV Class B (BMV:GAPB) declined 1.58% or 6.70 points to end at 416.82 and Grupo Aeroportuario Del CentroNorte (BMV:OMAB) was down 1.56% or 3.70 points to 234.19.

Falling stocks outnumbered advancing ones on the Mexico Stock Exchange by 120 to 117 and 11 ended unchanged.

Shares in Promotora y Operadora de Infraestructura SAB de CV (BMV:PINFRA) rose to all time highs; rising 3.32% or 8.37 to 260.23.

Gold Futures for February delivery was up 0.15% or 6.20 to $4,238.70 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 1.41% or 0.83 to hit $59.78 a barrel, while the February Brent oil contract rose 1.12% or 0.70 to trade at $63.37 a barrel.

USD/MXN was down 0.25% to 18.24, while EUR/MXN fell 0.47% to 21.23.

The US Dollar Index Futures was up 0.24% at 99.04.

Investing.com – Canada stocks were higher after the close on Thursday, as gains in the Healthcare, IT and Financials sectors led shares higher.

At the close in Toronto, the S&P/TSX Composite added 1.02% to hit a new all time high.

The best performers of the session on the S&P/TSX Composite were Descartes Systems Group Inc (TSX:DSG), which rose 14.37% or 16.64 points to trade at 132.45 at the close. Meanwhile, EQB Inc (TSX:EQB) added 12.85% or 11.16 points to end at 98.01 and MDA Ltd (TSX:MDA) was up 9.79% or 2.26 points to 25.34 in late trade.

The worst performers of the session were First Majestic Silver Corp. (TSX:AG), which fell 4.24% or 0.93 points to trade at 20.98 at the close. Ivanhoe Mines Ltd. (TSX:IVN) declined 3.40% or 0.53 points to end at 15.08 and Aya Gold & Silver Inc (TSX:AYA) was down 3.14% or 0.59 points to 18.21.

Rising stocks outnumbered declining ones on the Toronto Stock Exchange by 485 to 403 and 88 ended unchanged.

The S&P/TSX 60 VIX, which measures the implied volatility of S&P/TSX Composite options, was down 13.20% to 11.57.

Gold Futures for February delivery was up 0.15% or 6.30 to $4,238.80 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 1.41% or 0.83 to hit $59.78 a barrel, while the February Brent oil contract rose 1.12% or 0.70 to trade at $63.37 a barrel.

CAD/USD was unchanged 0.07% to 0.72, while CAD/EUR unchanged 0.18% to 0.62.

The US Dollar Index Futures was up 0.24% at 99.04.

Investing.com – Colombia stocks were higher after the close on Thursday, as gains in the Industrials, Services and Agriculture sectors led shares higher.

At the close in Colombia, the COLCAP rose 0.49% to hit a new all time high.

The best performers of the session on the COLCAP were Bolsa De Valores De Colombia (BVC:BVC), which rose 1.30% or 180.00 points to trade at 14,080.00 at the close. Meanwhile, Ecopetrol SA (BVC:ECO) added 1.06% or 20.00 points to end at 1,910.00 and Organizacion Terpel SA (BVC:TPL) was up 1.04% or 180.00 points to 17,480.00 in late trade.

The worst performers of the session were Grupo de Inversiones Suramericana SA Preferred (BVC:SIS_p), which fell 1.95% or 900.00 points to trade at 45,180.00 at the close. Interconnection Electric SA ESP (BVC:ISA) declined 1.71% or 440.00 points to end at 25,300.00 and Bancolombia Pf (BVC:BIC_p1) was down 1.57% or 960.00 points to 60,300.00.

Rising stocks outnumbered declining ones on the Colombia Stock Exchange by 1 to 0.

Shares in Organizacion Terpel SA (BVC:TPL) rose to 5-year highs; rising 1.04% or 180.00 to 17,480.00.

US coffee C for March delivery was up 1.70% or 6.35 to $378.80 . Elsewhere in commodities trading, US cocoa for delivery in March fell 0.15% or 8.00 to hit $5,496.00 , while the February Gold Futures contract rose 0.17% or 7.00 to trade at $4,239.50 a troy ounce.

USD/COP was up 0.89% to 3,804.00, while BRL/COP rose 0.77% to 716.92.

The US Dollar Index Futures was up 0.23% at 99.02.

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose 11% in after-hours trading on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on its tradipitant protocol for motion sickness treatment.

The FDA’s decision removes previous limitations that restricted the protocol VP-VLY-686-3403 to a maximum of 90 doses of tradipitant. The agency agreed with Vanda’s position that motion sickness represents an acute, self-limiting physiologic response rather than a chronic condition, eliminating the need for an additional six-month dog toxicity study.

This regulatory development allows Vanda to extend clinical studies of tradipitant in motion sickness. The resolution followed Vanda’s formal dispute resolution request and an expedited re-review conducted by FDA leadership under a collaborative framework established between the company and the agency in October 2025.

Separately, Vanda confirmed that the review of its New Drug Application for tradipitant for the prevention of motion-induced vomiting remains on track with a PDUFA target action date of December 30, 2025. If approved, tradipitant would be the first new pharmacologic treatment for motion sickness in over 40 years.

Mihael H. Polymeropoulos, President and CEO of Vanda, stated that "The swift and favorable resolution of this issue highlights the effectiveness of our collaborative framework with the FDA."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.